Giloralimab
Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer[1][2].
Product Specifications
CAS Number
[2226292-20-0]
Product Name Alternative
ABBV-927
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/giloralimab.html
Purity
96.10
Solubility
10 mM in DMSO
Smiles
[Giloralimab]
Molecular Weight
(145.26 kDa)
References & Citations
[1]Boulard P, et al. Finding the Right Heavy Chains for Immunostimulatory Antibodies. Int J Mol Sci. 2022 Sep 8;23 (18) :10367.|[2]Peng L, et al. Novel immunotherapeutic drugs for the treatment of lung cancer. Curr Opin Oncol. 2022 Jan 1;34 (1) :89-94.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6486021-01 0.2 mL
MIP3B, CT (C-C Motif Chemokine 19, Small Inducible Cytokine A19, Macrophage Inflammatory Protein 3 beta, MIP-3-beta, Epstein-Barr Virus-induced Molecule 1 Ligand Chemokine, EBI1-ligand Chemokine, ELC, Beta Chemokine Exodus-3, CK beta-11, CCL19, SCYA19) (P
Ask
View Details